Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Tumor protein p53 (TP53) is the most frequently mutated gene in cancer1,2. In patients with myelodysplastic syndromes (MDS), TP53 mutations are associated with high-risk disease3,4, rapid transformation to acute myeloid leukemia (AML)5, resistance to conventional therapies6,7,8 and dismal outcomes9....

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Bernard, E, Nannya, Y, Hasserjian, RP, Boultwood, J, Pellagatti, A
Định dạng:	Journal article
Ngôn ngữ:	English
Được phát hành:	Springer Nature 2020

Những quyển sách tương tự

NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q).
Bằng: Fidler, C, et al.
Được phát hành: (2004)

TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
Bằng: Ramy Rahmé, et al.
Được phát hành: (2023-04-01)

Rare case of myelodysplastic syndrome with near-tetraploidy and TP53 mutation
Bằng: Čolović Nataša, et al.
Được phát hành: (2023-01-01)

Clinical outcomes and characteristics of patients with TP53-mutated myelodysplastic syndromes
Bằng: Lijuan Zhang, et al.
Được phát hành: (2023-12-01)

TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups
Bằng: Haase, D, et al.
Được phát hành: (2019)

SF3B1 mutant myelodysplastic syndrome: Recent advances
Bằng: Pellagatti, A, et al.
Được phát hành: (2020)

TP53 mutation in newly diagnosed acute myeloid leukemia and myelodysplastic syndrome
Bằng: Pimjai Niparuck, et al.
Được phát hành: (2021-10-01)

Gene expression profiling in the myelodysplastic syndromes.
Bằng: Pellagatti, A, et al.
Được phát hành: (2005)

Splicing factor gene mutations in the myelodysplastic syndromes: impact on disease phenotype and therapeutic applications.
Bằng: Pellagatti, A, et al.
Được phát hành: (2016)

Molecular characterization of AML‐MRC reveals TP53 mutation as an adverse prognostic factor irrespective of MRC‐defining criteria, TP53 allelic state, or TP53 variant allele frequency
Bằng: Davidson Zhao, et al.
Được phát hành: (2023-03-01)

The role of splicing factor mutations in the pathogenesis of the myelodysplastic syndromes.
Bằng: Boultwood, J, et al.
Được phát hành: (2014)

TP53-mutated myelodysplastic syndrome and acute myeloid leukemia: biology, current therapy, and future directions
Bằng: Daver, NG, et al.
Được phát hành: (2022)

Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations
Bằng: Laurence Lodé, et al.
Được phát hành: (2018-01-01)

Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis
Bằng: Rashmi Kanagal-Shamanna, et al.
Được phát hành: (2021-03-01)

A tale of two alleles: TP53 and transformation in MPNs
Bằng: Brierley, C, et al.
Được phát hành: (2022)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation
Bằng: Liberante, F, et al.
Được phát hành: (2013)

High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation.
Bằng: Liberante, F, et al.
Được phát hành: (2013)

Transplantation for therapy-related, TP53-mutated myelodysplastic syndrome – not because we can, but because we should
Bằng: Corey Cutler
Được phát hành: (2017-12-01)

Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
Bằng: Fernando Barroso Duarte, et al.
Được phát hành: (2017-05-01)

Splicing factor mutations in the myelodysplastic syndromes: target genes and therapeutic approaches
Bằng: Armstrong, R, et al.
Được phát hành: (2017)

Bladder Myeloid Sarcoma with TP53 mutated Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap syndrome: Response to Decitabine-Venetoclax regimen
Bằng: Nikeeta Mandhan, et al.
Được phát hành: (2022-01-01)

Clonality in the myelodysplastic syndromes.
Bằng: Boultwood, J, et al.
Được phát hành: (2001)

To target the untargetable: elucidation of synergy of APR-246 and azacitidine in TP53 mutant myelodysplastic syndromes and acute myeloid leukemia
Bằng: David A. Sallman
Được phát hành: (2020-06-01)

PB1913: SYNERGISTIC EFFECTS OF DECITABINE AND APR-246 IN TP53 P.248Q-MUTATED MYELODYSPLASTIC SYNDROME
Bằng: Y. Fang, et al.
Được phát hành: (2022-06-01)

Prognostic heterogeneity and clonal dynamics within distinct subgroups of myelodysplastic syndrome and acute myeloid leukemia with TP53 disruptions
Bằng: Shyam A. Patel, et al.
Được phát hành: (2023-11-01)

Pulmonary infection associated with immune dysfunction is associated with poor prognosis in patients with myelodysplastic syndrome accompanied by TP53 abnormalities
Bằng: Yi Chen, et al.
Được phát hành: (2023-11-01)

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia
Bằng: Kathy L. McGraw, et al.
Được phát hành: (2016-08-01)

Molecular pathogenesis of the myelodysplastic syndromes
Bằng: Boultwood, J, et al.
Được phát hành: (1999)

Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome.
Bằng: Boultwood, J, et al.
Được phát hành: (2012)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
Bằng: Melania Tesio
Được phát hành: (2023-02-01)

Telomere length in myelodysplastic syndromes.
Bằng: Boultwood, J, et al.
Được phát hành: (1995)

Synergistic effects of PRIMA-1Met (APR-246) and 5-azacitidine in TP53-mutated myelodysplastic syndromes and acute myeloid leukemia
Bằng: Nabih Maslah, et al.
Được phát hành: (2020-06-01)

Allogeneic haematopoietic stem cell transplantation with decitabine-containing preconditioning regimen in TP53-mutant myelodysplastic syndromes: A case study
Bằng: Yuxin Wang, et al.
Được phát hành: (2022-07-01)

Gene expression profiling in 5q-syndrome and myelodysplastic syndromes.
Bằng: Pellagatti, A, et al.
Được phát hành: (2003)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
Bằng: Haiwei Wang, et al.
Được phát hành: (2022-06-01)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
Bằng: Doolittle, H
Được phát hành: (2017)

Genomic Characterization of TP53–Wild-Type Esophageal Carcinoma
Bằng: Alexander Quaas, et al.
Được phát hành: (2019-01-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
Bằng: Pellagatti, A, et al.
Được phát hành: (2008)

P066: Variant overlooked: A partial deficiency TP53 allele that skirts interpretation criteria
Bằng: Lisa Lansdon, et al.
Được phát hành: (2023-01-01)

Clinical and biological implications of driver mutations in myelodysplastic syndromes.
Bằng: Papaemmanuil, E, et al.
Được phát hành: (2013)